In the current dynamic market landscape and in the foreseeable future, major players in the In Vitro Diagnostics (IVD) industry are compelled to navigate the evolving demands by upholding innovation, reliability, and a steadfast commitment to quality. 

Leveraging our expertise in immunoassay development and manufacturing, we possess a keen understanding of the challenges that immunoassay manufacturers encounter when striving to meet the heightened demand. This demand pertains not only to the final immunoassay but also extends to critical biomaterials, such as antigens and antibodies.

At Werfen, we work alongside our partners to help them meet their operational and quality needs  

Our Approach

When providing immunoassays and biomaterials to the IVD industry, alignment with the demands of your partners is key. It is crucial to possess the flexibility to accommodate potential increases in their requirements. At our technological center, we are working to have a dedicated area validated for the large-scale manufacturing of crucial immunoassay components.

Beyond its manufacturing scale, one of the defining features of this area is its ability to adapt to various formulations, ensuring readiness to meet any potential new demands from our partners